MABF982 Sigma-AldrichAnti-Complement C3b/iC3b Antibody, clone 6C9
This mouse monoclonal Anti-Complement C3b/iC3b Antibody, clone 6C9, Cat. No. MABF982 is validated for use in Flow Cytometry, for the detection of C3b.
More>> This mouse monoclonal Anti-Complement C3b/iC3b Antibody, clone 6C9, Cat. No. MABF982 is validated for use in Flow Cytometry, for the detection of C3b. Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H, M | FC | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG1κ antibody in buffer containing PBS without preservatives. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| MABF982 | 04055977177084 |
Documentation
Anti-Complement C3b/iC3b Antibody, clone 6C9 SDS
| Title |
|---|
Anti-Complement C3b/iC3b Antibody, clone 6C9 Certificates of Analysis
| Title | Lot Number |
|---|---|
| Anti-Complement C3b/iC3b, clone 6C9 - 3278811 | 3278811 |
| Anti-Complement C3b/iC3b, clone 6C9 - 3508314 | 3508314 |
| Anti-Complement C3b/iC3b, clone 6C9 - 3887041 | 3887041 |
| Anti-Complement C3b/iC3b, clone 6C9 - 4269957 | 4269957 |
| Anti-Complement C3b/iC3b, clone 6C9 - 4320451 | 4320451 |
| Anti-Complement C3b/iC3b, clone 6C9 -Q2583308 | Q2583308 |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



